Access

News and Views


Nature Medicine 8, 1082 - 1083 (2002)
doi:10.1038/nm1002-1082

Attacked from within, blood thins

Wadie F. Bahou1

  1. Departments of Medicine and Program in Genetics, State University of New York, Stony Brook, New York, USA e-mail: wbahou@notes.cc.sunysb.edu


Thrombin leads to blood clotting through activation of specialized G protein–coupled receptors. In mice, small peptides call pepducins inhibit thrombin receptors and prevent blood clotting (pages 1161–1165).


Blood clotting is controlled by a tightly regulated cascade of proteases and their cofactors that sequentially leads to generation of a gelatinous meshwork composed of a protein called fibrin. This coagulation cascade ensures the normal cessation of blood flow that occurs during physiologic processes such as menstruation, or during recovery from injury, and is termed hemostasis.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
Cardiovascular biology: Platelets and proteases
Nature News and Views (06 Sep 2001)

RESEARCH
Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation
Nature Medicine Article (01 Oct 2002)
Reply to "Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin"
Nature Medicine Correspondence (01 Dec 2003)
Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin
Nature Medicine Correspondence (01 Dec 2003)

$rb.Type.Code